What is the share price of Ngl Fine Chem Ltd (NGLFINE) today?
The share price of NGLFINE as on 5th December 2025 is ₹1299.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Ngl Fine Chem Ltd (NGLFINE) share?
The past returns of Ngl Fine Chem Ltd (NGLFINE) share are- Past 1 week: -3.90%
- Past 1 month: -20.09%
- Past 3 months: -13.56%
- Past 6 months: 22.24%
- Past 1 year: -30.61%
- Past 3 years: -22.45%
- Past 5 years: -30.47%
What are the peers or stocks similar to Ngl Fine Chem Ltd (NGLFINE)?
The peers or stocks similar to Ngl Fine Chem Ltd (NGLFINE) include:What is the dividend yield % of Ngl Fine Chem Ltd (NGLFINE) share?
The current dividend yield of Ngl Fine Chem Ltd (NGLFINE) is 0.13.What is the market cap of Ngl Fine Chem Ltd (NGLFINE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ngl Fine Chem Ltd (NGLFINE) is ₹802.83 Cr as of 5th December 2025.What is the 52 week high and low of Ngl Fine Chem Ltd (NGLFINE) share?
The 52-week high of Ngl Fine Chem Ltd (NGLFINE) is ₹2077.45 and the 52-week low is ₹957.What is the PE and PB ratio of Ngl Fine Chem Ltd (NGLFINE) stock?
The P/E (price-to-earnings) ratio of Ngl Fine Chem Ltd (NGLFINE) is 37.99. The P/B (price-to-book) ratio is 2.84.Which sector does Ngl Fine Chem Ltd (NGLFINE) belong to?
Ngl Fine Chem Ltd (NGLFINE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Ngl Fine Chem Ltd (NGLFINE) shares?
You can directly buy Ngl Fine Chem Ltd (NGLFINE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Ngl Fine Chem Ltd
NGLFINE Share Price
1,299.500.28% (-3.70)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
NGLFINE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
NGLFINE Performance & Key Metrics
NGLFINE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 38.80 | 2.84 | 0.13% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.87 | 5.82 | 0.59% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
NGLFINE Company Profile
NGL Fine-Chem Limited is manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health.
SUNPHARMA
PE Ratio
39.63
39.63
1Y Return
0.45%
0.45%
Buy Reco %
91.67
91.67
TORNTPHARM
PE Ratio
67.04
67.04
1Y Return
12.63%
12.63%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
23.30
23.30
1Y Return
1.51%
1.51%
Buy Reco %
70.00
70.00
DRREDDY
PE Ratio
18.77
18.77
1Y Return
2.85%
2.85%
Buy Reco %
41.94
41.94
LUPIN
PE Ratio
29.21
29.21
1Y Return
1.24%
1.24%
Buy Reco %
72.22
72.22
NGLFINE Sentiment Analysis
NGLFINE Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
NGLFINE Stock Summary · November 2025
The company is witnessing a steady recovery in demand, particularly in the Indian and Asia Pacific markets, which has positively impacted revenue and EBITDA for the recent quarter. However, rising operational costs, including a significant increase in outsourcing and salary expenses, have pressured profit margins, leading to a slight decline in profit after tax. While management remains optimistic about future growth driven by ongoing capital projects and strategic market expansions, particularly in the U.S. and EU, regulatory approvals pose a challenge. The company is focused on maintaining a disciplined capital expenditure program to enhance production capacity, despite the complexities of navigating a competitive landscape and managing debt effectively. Overall, while the outlook is cautiously optimistic, achieving ambitious revenue targets may prove challenging amidst these operational hurdles.
NGLFINE Stock Growth Drivers
NGLFINE Stock Growth Drivers
7Strong Financial Performance
NGL Fine-Chem Limited has reported significant financial growth, with Q2 FY '26 revenue from operations
Operational Capacity and Market Demand
The company has resumed outsourcing to meet strong demand, ensuring timely delivery and efficient customer
NGLFINE Stock Challenges
NGLFINE Stock Challenges
4Decline in EBITDA Margins
The company has experienced a significant decline in EBITDA margins since FY '23, despite a
Challenges in Capacity Measurement and Market Competition
The company faces challenges in defining production capacity in relation to sales due to the
NGLFINE Forecast
NGLFINE Forecasts
Price
Revenue
Earnings
NGLFINE Company Revenue Forecast
NGLFINE Company Revenue Forecast
2025
Current
₹376.89
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2025
Current
₹376.89
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
NGLFINE Stock EPS (Earnings Per Share) Forecast
NGLFINE Stock EPS (Earnings Per Share) Forecast
2025
Current
₹34.20
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹34.20
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
NGLFINE
NGLFINE
Income
Balance Sheet
Cash Flow
Annual Normal View
NGLFINE Income Statement
NGLFINE Income Statement
Annual Normal View
| Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 157.29 | 154.74 | 265.99 | 328.18 | 283.61 | 352.82 | 376.89 | 415.83 | ||||||||
Raw Materials | 65.29 | 71.02 | 102.62 | 172.27 | 118.75 | 173.47 | 185.04 | 368.96 | ||||||||
| Power & Fuel Cost | 8.71 | 9.99 | 9.85 | 15.86 | 18.53 | 23.25 | 26.03 | |||||||||
| Employee Cost | 21.16 | 24.04 | 28.09 | 34.85 | 36.87 | 45.12 | 55.55 | |||||||||
| Selling & Administrative Expenses | 10.22 | 8.00 | 11.62 | 8.69 | 11.55 | 14.91 | 15.97 | |||||||||
| Operating & Other expenses | 15.50 | 18.87 | 25.69 | 17.64 | 57.42 | 28.19 | 50.87 | |||||||||
EBITDA | 36.41 | 22.82 | 88.12 | 78.87 | 40.49 | 67.88 | 43.43 | 46.87 | ||||||||
| Depreciation/Amortization | 6.30 | 8.11 | 8.33 | 10.37 | 11.29 | 11.64 | 12.45 | 15.78 | ||||||||
| PBIT | 30.11 | 14.71 | 79.79 | 68.50 | 29.20 | 56.24 | 30.98 | 31.09 | ||||||||
| Interest & Other Items | 2.55 | 2.63 | 2.20 | 1.91 | 1.83 | 1.81 | 3.26 | 3.95 | ||||||||
| PBT | 27.56 | 12.08 | 77.59 | 66.59 | 27.37 | 54.43 | 27.72 | 27.14 | ||||||||
| Taxes & Other Items | 7.44 | 3.73 | 20.87 | 16.70 | 6.87 | 13.11 | 6.59 | 6.45 | ||||||||
| Net Income | 20.12 | 8.35 | 56.72 | 49.89 | 20.50 | 41.32 | 21.13 | 20.69 | ||||||||
| EPS | 32.57 | 13.52 | 91.81 | 80.75 | 33.18 | 66.88 | 34.20 | 33.49 | ||||||||
| DPS | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | ||||||||
| Payout ratio | 0.05 | 0.13 | 0.02 | 0.02 | 0.05 | 0.03 | 0.05 | 0.05 |
NGLFINE Company Updates
FY 2026FY 2026
Investor Presentation
Nov 14PDF
Aug 7PDF
NGLFINE Stock Peers
NGLFINE Past Performance & Peer Comparison
NGLFINE Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ngl Fine Chem Ltd | 37.99 | 2.84 | 0.13% |
| Sun Pharmaceutical Industries Ltd | 39.63 | 5.98 | 0.89% |
| Torrent Pharmaceuticals Ltd | 67.04 | 16.88 | 0.85% |
| Cipla Ltd | 23.30 | 3.93 | 1.05% |
NGLFINE Stock Price Comparison
Compare NGLFINE with any stock or ETFCompare NGLFINE with any stock or ETF
NGLFINE
NGLFINE Holdings
NGLFINE Shareholdings
NGLFINE Promoter Holdings Trend
NGLFINE Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
NGLFINE Institutional Holdings Trend
NGLFINE Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
NGLFINE Shareholding Pattern
NGLFINE Shareholding Pattern
NGLFINE Shareholding History
NGLFINE Shareholding History
Foreign Institutions
Mutual Funds Invested in NGLFINE
Mutual Funds Invested in NGLFINE
No mutual funds holding trends are available
Top 1 Mutual Funds holding Ngl Fine Chem Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0000% | Percentage of the fund’s portfolio invested in the stock 0.00% | Change in the portfolio weight of the stock over the last 3 months -0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 123/124 (0) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing NGLFINE stock
smallcases containing NGLFINE stock
Looks like this stock is not in any smallcase yet.
NGLFINE Events
NGLFINE Events
NGLFINE Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
NGLFINE has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.13%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.35 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
NGLFINE Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
NGLFINE has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.13%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.35 every year
NGLFINE Upcoming Dividends
NGLFINE Upcoming Dividends
No upcoming dividends are available
NGLFINE Past Dividends
NGLFINE Past Dividends
Cash Dividend
Ex DateEx DateAug 12, 2025
Final
Final | Div/Share: ₹1.75
Dividend/Share
₹1.75
Ex DateEx Date
Aug 12, 2025
Cash Dividend
Ex DateEx DateAug 16, 2024
Final
Final | Div/Share: ₹1.75
Dividend/Share
₹1.75
Ex DateEx Date
Aug 16, 2024
Cash Dividend
Ex DateEx DateAug 18, 2023
Final
Final | Div/Share: ₹1.75
Dividend/Share
₹1.75
Ex DateEx Date
Aug 18, 2023
Cash Dividend
Ex DateEx DateJun 22, 2022
Final
Final | Div/Share: ₹1.75
Dividend/Share
₹1.75
Ex DateEx Date
Jun 22, 2022
Cash Dividend
Ex DateEx DateAug 12, 2021
Final
Final | Div/Share: ₹1.75
Dividend/Share
₹1.75
Ex DateEx Date
Aug 12, 2021
NGLFINE Stock News & Opinions
NGLFINE Stock News & Opinions
Articles & Videos
Earnings
NGL Fine Chem consolidated net profit declines 1.83% in the September 2025 quarter
Net profit of NGL Fine Chem declined 1.83% to Rs 9.63 crore in the quarter ended September 2025 as against Rs 9.81 crore during the previous quarter ended September 2024. Sales rose 28.65% to Rs 120.26 crore in the quarter ended September 2025 as against Rs 93.48 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales120.2693.48 29 OPM %14.2712.36 - PBDT18.0516.36 10 PBT12.9613.33 -3 NP9.639.81 -2 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
NGL Fine-Chem to announce Quarterly Result
NGL Fine-Chem will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
NGL Fine Chem consolidated net profit rises 0.22% in the June 2025 quarter
Net profit of NGL Fine Chem rose 0.22% to Rs 9.24 crore in the quarter ended June 2025 as against Rs 9.22 crore during the previous quarter ended June 2024. Sales rose 14.81% to Rs 104.19 crore in the quarter ended June 2025 as against Rs 90.75 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales104.1990.75 15 OPM %10.5410.31 - PBDT16.1114.79 9 PBT11.8411.79 0 NP9.249.22 0 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
NGL Fine-Chem to convene board meeting
NGL Fine-Chem will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
NGL Fine-Chem to hold AGM
NGL Fine-Chem announced that the 44th Annual General Meeting(AGM) of the company will be held on 19 May 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
NGL Fine Chem fixes record date for final dividend
NGL Fine Chem has fixed 12 August 2025 as record date for payment of final dividend. The dividend will be paid on or after 26 August 2025. Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Board of NGL Fine-Chem recommends final dividend
NGL Fine-Chem announced that the Board of Directors of the Company at its meeting held on 22 May 2025, inter alia, have recommended the final dividend of Rs 1.75 per equity Share (i.e. 35%) , subject to the approval of the shareholders.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
NGL Fine Chem consolidated net profit declines 95.62% in the March 2025 quarter
Net profit of NGL Fine Chem declined 95.62% to Rs 0.54 crore in the quarter ended March 2025 as against Rs 12.32 crore during the previous quarter ended March 2024. Sales declined 4.80% to Rs 94.97 crore in the quarter ended March 2025 as against Rs 99.76 crore during the previous quarter ended March 2024. For the full year,net profit declined 48.89% to Rs 21.12 crore in the year ended March 2025 as against Rs 41.32 crore during the previous year ended March 2024. Sales rose 8.73% to Rs 368.26 crore in the year ended March 2025 as against Rs 338.69 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales94.9799.76 -5 368.26338.69 9 OPM %6.6515.86 -9.2015.73 - PBDT4.3819.01 -77 40.1766.06 -39 PBT1.0616.09 -93 27.7154.42 -49 NP0.5412.32 -96 21.1241.32 -49 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
NGL Fine-Chem to convene board meeting
NGL Fine-Chem will hold a meeting of the Board of Directors of the Company on 22 May 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Spotlight
ICRA affirms ratings of NGL Fine-Chem at 'BBB+/A' with 'stable' outlook
The agency has also affirmed the company's short-term rating at '[ICRA] A2'. ICRA stated that the reaffirmation of ratings of NGL Fine-Chem (NGL) factors in the company's established operational track record, the extensive experience of its management in the animal health active pharmaceutical ingredients (API) segment, its diversified geographical presence in domestic and international markets and its well-established client base built over the years. Also, NGL continues to maintain a strong market share for its top three APIs (diminazene, clorsulon and buparvaquone), supported by a competitive cost proposition since it is partly backward integrated for basic chemicals. Going forward, topline growth is expected tobe supported by improvement in realisations, penetration in new geographies and expansion of itsproduct line. The ratings, however, remain constrained by the moderate scale of operations and high working capital intensity of NGL's business, stemming from receivables and an elevated inventory holding cycle. Also, the company's profitability remains vulnerable to volatility in raw material prices, as demonstrated in FY2023. Moreover, given the nature of short-term contracts, the company's operating profitability remains exposed to the movements in the raw materials prices that cannot be passed onto customers. NGL Fine-Chem is a veterinary API manufacturer and its products are used in the animal health care industry. NGL had acquired a 100% stake in Macrotech Polychem (MPPL) in May 2019. MPPL manufactures pharmaceutical intermediates and serves as the backward integrated unit for the company. The scrip had shed 0.10% to end at Rs 1089 on the BSE today. Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 19.49%, vs industry avg of 10.04%
Over the last 5 years, market share increased from 0.06% to 0.09%
Over the last 5 years, net income has grown at a yearly rate of 20.4%, vs industry avg of 20.02%